SS
CGON icon

SBI Securities’s CG Oncology CGON Stock Holding History

SBI Securities’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.11K Hold
100
– – ﹤0.01% 2013
2026
Q1 		$6.77K Buy
100
+49
+96% +$2.78K ﹤0.01% 1899
2025
Q4 		$2.12K Sell
51
-400
-89% -$16.6K ﹤0.01% 2355
2025
Q3 		$18.2K Buy
451
+151
+50% +$4.39K ﹤0.01% 1490
2025
Q2 		$7.8K Buy
300
+100
+50% +$2.41K ﹤0.01% 1807
2025
Q1 		$4.9K Buy
200
+100
+100% +$2.81K ﹤0.01% 1910
2024
Q4 		$2.87K Buy
+100
New +$3.42K ﹤0.01% 2142

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities's CGON Position: Q2 2026 in Review

SBI Securities held its CG Oncology (CGON) position steady in Q2 2026 at 100 shares worth $7.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2013.

SBI Securities first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.2K in Q3 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • SBI Securities held 100 shares of CG Oncology worth $7.11K as of Q2 2026.
  • SBI Securities left its CG Oncology share count unchanged in Q2 2026.
  • CG Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2013 holding.
  • SBI Securities first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's CG Oncology position peaked at $18.2K in Q3 2025.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.